A tailored implementation intervention to implement recommendations addressing polypharmacy in multimorbid patients: study protocol of a cluster randomized controlled trial

Trials

Joachim Szecsenyi²  Michel Wensing¹  Stefanie Joos²  Jost Steinhäuser²  Tobias Freund²  Cornelia Jäger² 

[1]Scientific Institute for Quality of Healthcare, Radboud University, Medical Centre, PO Box 9101, 114 IQ healthcare, 6500 HB Nijmegen, The Netherlands

[2]Department of General Practice and Health Services Research, University Hospital Heidelberg, Voßstrasse 2, Heidelberg 69115, Germany

关键词: Tailored intervention;    Primary care;    Polypharmacy;    Knowledge transfer;    Implementation;    Guideline;   

Others  :  807837
DOI  :  10.1186/1745-6215-14-420

 received in 2013-08-19, accepted in 2013-11-13,  发布年份 2013

【 摘 要 】

Background

Multimorbid patients frequently receive complex medication regimens and are at higher risk for adverse drug reactions and hospitalisations. Managing patients with polypharmacy is demanding, because it requires coordination of multiple prescribers and intensive monitoring. Three evidence-based recommendations addressing polypharmacy in primary care are structured medication counselling, use of medication lists and medication reviews to avoid potentially inappropriate medication (PIM). Although promising to improve patient outcomes, these recommendations are not well implemented in German routine care. Implementation of guidelines is often hindered by specific “determinants of change”. “Tailored” interventions are designed to specifically address previously identified determinants. This study examines a tailored intervention tto implement the aforementioned recommendations into German primary care practices. This study is part of the European Tailored Interventions for Chronic Diseases project, which aims at contributing knowledge about the methods used for tailoring.

Methods/Design

The study is designed as a cluster randomized controlled trial with primary care practices of general practitioners (GPs) who are organized in quality circles. Quality circles will be the unit of randomization with a 1:1 ratio. Follow-up time is 6 months. GPs and healthcare assistants in the intervention group will receive training on medication management. Each GP will create a tailored concept of how to implement the three recommendations into his/her practice. Evidence-based checklists for medication counselling and medication reviews will be provided for physicians. A tablet PC with an interactive educational tool and information leaflets will be provided for use by patients to inform about the necessity of continuous medication management. Control practices will not receive special training and will provide care as usual. Primary outcome is the degree of implementation of the three recommendations, which will be measured using a prespecified set of indicators. Additionally, the PIM prescription rate, patient activation, patients’ beliefs about medicine, medication adherence and patients’ social support will be measured.

Discussion

This study will contribute knowledge about the feasibility of implementing recommendations for managing patients with polypharmacy in primary care practices. Additionally, this study will contribute knowledge about methods for tailoring of implementation interventions.

Trial registration

Clinicaltrials.govISRCTN34664024

【 授权许可】

   
2013 Jäger et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Fig.1.

【 参考文献 】

• [1]Tinetti ME, Fried TR, Boyd CM: Designing health care for the most common chronic condition—multimorbidity. JAMA 2012, 307:2493-2494.
• [2]Gnjidic D, Hilmer SN, Blyth FM, Naganathan V, Waite L, Seibel MJ, McLachlan AJ, Cumming RG, Handelsman DJ, Le Couteur DG: Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 2012, 65:989-995.
• [3]Taché SV, Sönnichsen A, Ashcroft DM: Prevalence of adverse drug events in ambulatory care: a systematic review. Ann Pharmacother 2011, 45:977-989.
• [4]Beijer HJ, de Blaey CJ: Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharm World Sci 2002, 24:46-54.
• [5]Hakkarainen KM, Hedna K, Petzold M, Hägg S: Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions: a meta-analysis. PLoS One 2012, 7:e33236.
• [6]Patterson SM, Hughes C, Kerse N, Cardwell CR, Bradley MC: Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Database Syst Rev 2012., 5CD008165
• [7]Harrington NG, Noar SM: Reporting standards for studies of tailored interventions. Health Educ Res 2012, 27:331-342.
• [8]Room for review. A guide to medication review: the agenda for patients, practitioners and managers [ http://www.npc.nhs.uk/review_medicines/intro/resources/room_for_review.pdf webcite]
• [9]Breitenstein SM, Gross D, Garvey CA, Hill C, Fogg L, Resnick B: Implementation fidelity in community-based interventions. Res Nurs Health 2010, 33:164-173.
• [10]Holt S, Schmiedl S, Thürmann PA: Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int 2010, 107:543-551.
• [11]Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ: A summated score for the Medication Appropriateness Index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 1994, 47:891-896.
• [12]Calkins DR, Davis RB, Reiley P, Phillips RS, Pineo KL, Delbanco TL, Iezzoni LI: Patient-physician communication at hospital discharge and patients’ understanding of the postdischarge treatment plan. Arch Intern Med 1997, 157:1026-1030.
• [13]Cumbler E, Wald H, Kutner J: Lack of patient knowledge regarding hospital medications. J Hosp Med 2010, 5:83-86.
• [14]Stevenson FA, Cox K, Britten N, Dundar Y: A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 2004, 7:235-245.
• [15]Mahler C, Jank S, Hermann K, Haefeli WE: Szecsenyi J: [Information on medications: how do chronically ill patients assess counselling on drugs in general practice?] [in German]. Dtsch Med Wochenschr 2009, 134:1620-1624.
• [16]Mahler C, Hermann K, Jank S, Haefeli WE, Szecsenyi J: Can a feedback report and training session on medication counseling for general practitioners improve patient satisfaction with information on medicines? Patient Prefer Adherence 2012, 6:179-186.
• [17]Hope CJ, Wu J, Tu W, Young J, Murray MD: Association of medication adherence, knowledge, and skills with emergency department visits by adults 50 years or older with congestive heart failure. Am J Health Syst Pharm 2004, 61:2043-2049.
• [18]Aylward MJ, Rogers T, Duane PG: Inaccuracy in patient handoffs: discrepancies between resident-generated reports and the medical record. Minn Med 2011, 94:38-41.
• [19]Balon J, Thomas SA: Comparison of hospital admission medication lists with primary care physician and outpatient pharmacy lists. J Nurs Scholarsh 2011, 43:292-300.
• [20]Ekedahl A, Brosius H, Jonsson J, Karlsson H, Yngvesson M: Discrepancies between the electronic medical record, the prescriptions in the Swedish national prescription repository and the current medication reported by patients. Pharmacoepidemiol Drug Saf 2011, 20:1177-1183.
• [21]Tulner LR, Kuper IM, Frankfort SV, van Campen JP, Koks CH, Brandjes DP, Beijnen JH: Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. Am J Geriatr Pharmacother 2009, 7:93-104.
• [22]Schmiemann G, Bahr M, Gurjanov A, Hummers-Pradier E: Differences between patient medication records held by general practitioners and the drugs actually consumed by the patients. Int J Clin Pharmacol Ther 2012, 50:614-617.
• [23]Amann U, Schmedt N, Garbe E: Prescribing of potentially inappropriate medications for the elderly: an analysis based on the PRISCUS list. Dtsch Arztebl Int 2012, 109:69-75.
• [24]Koper D, Kamenski G, Flamm M, Böhmdorfer B, Sönnichsen A: Frequency of medication errors in primary care patients with polypharmacy. Fam Pract 2013, 30:313-319.
• [25]Freund T, Szecsenyi J: Ose D: [Characteristics of beneficiaries of a GP-centred health care contract in Germany] [in German]. Med Klin (Munich) 2010, 105:808-811.
• [26]Wensing M, Broge B, Riens B, Kaufmann-Kolle P, Akkermans R, Grol R, Szecsenyi J: Quality circles to improve prescribing of primary care physicians: three comparative studies. Pharmacoepidemiol Drug Saf 2009, 18:763-769.
• [27]Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson N: Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2010., 3CD005470
• [28]Wensing M, Oxman A, Baker R, Godycki-Cwirko M, Flottorp S, Szecsenyi J, Grimshaw J, Eccles M: Tailored Implementation for Chronic Diseases (TICD): a project protocol. Implement Sci 2011, 6:103. BioMed Central Full Text
• [29]Wensing M, Broge B, Kaufmann-Kolle P, Andres E, Szecsenyi J: Quality circles to improve prescribing patterns in primary medical care: what is their actual impact? J Eval Clin Pract 2004, 10:457-466.
• [30]Altiner A, Schäfer I, Mellert C, Löffler C, Mortsiefer A, Ernst A, Stolzenbach CO, Wiese B, Scherer M, van den Bussche H, Kaduszkiewicz H: Activating GENeral practitioners dialogue with patients on their Agenda (MultiCare AGENDA) study protocol for a cluster randomized controlled trial. BMC Fam Pract 2012, 13:118. BioMed Central Full Text
• [31]Hibbard JH, Stockard J, Mahoney ER, Tusler M: Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res 2004, 39:1005-1026.
• [32]Mahler C, Hermann K, Horne R, Ludt S, Haefeli WE, Szecsenyi J, Jank S: Assessing reported adherence to pharmacological treatment recommendations: translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract 2010, 16:574-579.
• [33]Horne R, Weinman J, Hankins M: The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999, 14:1-24.
• [34]Fydrich T, Sommer G, Tydecks S, Brähler E: Social Support Questionnaire (F-SozU): standardization of short form (K-14) [Fragebogen zur sozialen Unterstützung (F-SozU): Normierung der Kurzform (K-14)]. Zeitschrift für Medizinische Psychologie 2009, 18:43-48.
• [35]Teerenstra S, Moerbeek M, van Achterberg T, Pelzer BJ, Borm GF: Sample size calculations for 3-level cluster randomized trials. Clin Trials 2008, 5:486-495.
• [36]Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group: CONSORT 2010 statement: extension to cluster randomised trials. BMJ 2012, 345:e5661.
• [37]Hox J: Multilevel Analysis: Techniques and Applications. 2nd edition. New York: Routledge; 2010.
• [38]Hildebrand MW, Host HH, Binder EF, Carpenter B, Freedland KE, Morrow-Howell N, Baum CM, Doré P, Lenze EJ: Measuring treatment fidelity in a rehabilitation intervention study. Am J Phys Med Rehabil 2012, 91:715-724.